1094-1095 / 1578
Modalities for pulmonary oligometastases
•
Consecutive patients (2007-2010)
•
Surgery
was preferred, with
SABR
preferred for unfit cases
•
110 patients (surgery, n=68; SABR, n=42)
•
Estimated OS rates at 3 and 5 years:
–62% and 41% for surgery
–60% and 49% for SABR
•
2-year local control: 94% - SABR, 90% - surgery
•
Progression-free survival at three years: 17%
Widder J, Radioth Oncol 2013